HPR129 Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products
Abstract
Authors
Nicolas S.H. Xander Maximilian Salcher-Konrad Anne Hendrickx Frederick W. Thielen Carin A. Uyl-De Groot